Lambda Phage Display Constructs for Gene Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for delivering genetic material using bacteriophages, such as lambda phage, are limited in their ability to efficiently express and display foreign genes, particularly in a controlled and targeted manner, and lack effective strategies for optimizing phage particle assembly and safety features to prevent environmental multiplication.
Innovation Solution
A system involving a nucleic acid molecule encoding the lambda phage D gene with specific nucleotide sequences, combined with a lambda pR promoter and a Shine-Delgarno sequence, is used to create recombinant lambda phage particles. This system includes methods for optimizing phage assembly by varying temperature and incorporating safety features to prevent phage multiplication, allowing for the expression and display of genes of interest on the phage surface and within eukaryotic cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If lambda phage is used to deliver genetic material, then gene delivery capability is improved, but control over phage assembly and safety is insufficient
Solution Approach 1:
The lambda phage genome is divided into functional modules: the D gene is separated from the genomic DNA, with D protein expression controlled by the pR promoter while genomic DNA contains a eukaryotic expression cassette. This segmentation allows independent optimization of phage assembly (via D protein) and gene delivery (via genomic DNA), resolving the contradiction between delivery versatility and assembly control.
Solution Approach 2:
Temperature is used as a control parameter to regulate phage assembly. The patent optimizes assembly temperature to balance efficient particle formation with safety, preventing uncontrolled multiplication while maintaining delivery capability. This parameter change provides the needed reliability control.
2Productivity
If temperature is varied to optimize phage assembly, then assembly efficiency is improved, but process complexity increases
Solution Approach 1:
Temperature is changed as a simple physical parameter to control phage assembly efficiency. By optimizing the temperature at which D protein is expressed and assembled into particles, the patent improves productivity without requiring complex equipment or procedures—only temperature control is needed.
Solution Approach 2:
The system uses the host cell's existing temperature-regulated expression machinery to control D protein production and phage assembly. The pR promoter responds naturally to temperature changes, allowing the system to self-regulate assembly efficiency without external intervention beyond simple temperature variation.
3Productivity
If D gene sequence is modified to improve particle assembly, then assembly efficiency is improved, but risk of environmental multiplication increases
Solution Approach 1:
The D gene is provided separately from the lambda phage genomic DNA that is packaged into particles. The D protein is expressed from a modified sequence under pR promoter control to improve assembly, while the packaged genomic DNA contains only the eukaryotic expression cassette without functional bacterial phage genes. This segmentation allows improved assembly efficiency while preventing environmental multiplication, as the packaged DNA cannot produce infectious phage.
Solution Approach 2:
The patent creates non-replicating phage particles that serve as disposable delivery vehicles. The D gene modifications improve particle formation, but the packaged genomic DNA is designed to be inert in the environment—unable to multiply or propagate. These particles fulfill their delivery function and then are discarded, eliminating the risk of environmental multiplication while maintaining assembly efficiency.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables efficient and controlled expression of genes of interest on the phage surface and within eukaryotic cells, optimizing phage particle assembly, and ensuring safety by preventing environmental phage multiplication, thus providing a versatile tool for gene delivery and therapeutic applications.
Implementation Method 1
an expression system comprising a nucleic acid molecule comprising lambda pR promoter having a nucleotide sequence as set forth in SEQ ID No. 2 operably linked to a nucleic acid molecule encoding lambdaphage D gene
Implementation Method 2
nucleic acid molecule encoding a Shine-Delgarno sequence as set forth in SEQ ID No. 4, operably linked to a nucleic acid molecule encoding lambdaphage D gene
Implementation Method 3
growing a plurality of cultures of said permissive host bacterial cell, each respective culture being grown at a temperature between 34-44° C.; and determining the number of phage particles produced in each respective culture, thereby determining the optimal temperature for phage assembly
Data Source
AI summary
Bacteriophages in general and lambda phage in particular are powerful, flexible reagents who have yet to be exploited to their full potential. As discussed herein, the lambda phage head and/or genome comprises an easy to use and highly efficient delivery vehicle for delivering the expression products of a gene of interest systemically or to a particular tissue.